About Tango Therapeutics, Inc. 
Tango Therapeutics, Inc.
Pharmaceuticals & Biotechnology
BCTG Acquisition Corp is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. It intends to focus on businesses that have their primary operations located in North America and Europe in the biotechnology industry. It has not generated any revenues.
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 44 Schemes (22.51%)
Foreign Institutions
Held by 73 Foreign Institutions (12.41%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
-39 Million
Pharmaceuticals & Biotechnology
USD 758 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.32
-107.86%
5.61






